Trademarkia Logo

Canada

C$
Rhodiolife
SEARCHED

on 17 Dec 2024

Last Applicant/ Owned by

NEKTIUM PHARMA S.L.

CALLE LAS MIMOSAS, Nº8(POLIGONO INDUSTRIAL ARINAGA)E-35118 AGUIMES

ES

Serial Number

2282373 filed on 17th Aug 2023

Correspondent Address

PERRY + CURRIER

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

CA

M4T1X3

Rhodiolife

Trademark usage description

extracts of medicinal plants; extracts of medicinal herbs; herbal extracts for medical purposes; plant extracts for pharmaceutical purposes; dietary s Read More

Classification Information


Class [005]
Extracts of medicinal plants; extracts of medicinal herbs; herbal extracts for medical purposes; plant extracts for pharmaceutical purposes; dietary supplements; natural dietary supplements to enhance physical performance and stress support; nutritional supplements; herbal supplements; food supplements; fitness and endurance supplements; nutraceuticals for therapeutic purposes; nutraceuticals for use as a dietary supplement; botanical extracts for use as nutraceuticals and dietary supplements; protein dietary supplements; vitamin supplements; dietary supplements for tiredness and fatigue; dietary supplements for animals; food supplements for veterinary use; vitamin supplements for animals.


Classification kind code

12

Mark Details


Serial Number

2282373

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 10th Jan 2025
Agent Changed
Submitted for opposition 22
on 17th Dec 2024
Search Recorded
Submitted for opposition 20
on 17th Dec 2024
Examiner's First Report
Submitted for opposition 223
on 17th Dec 2024
Total Provisional Refusal
Submitted for opposition 256
on 22nd Jul 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 21st Sept 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 20th Sept 2023
Formalized
Submitted for opposition 1
on 20th Sept 2023
Created
Submitted for opposition 228
on 17th Aug 2023
International Registration
Submitted for opposition 30
on 17th Aug 2023
Filed